REMI
Remedent, Inc. engags in the research, development, and manufacturing of oral care and cosmetic dentistry products. Its products include river 8, prefab veneer, and condor. The company was founded on September 30, 1996 and is headquartered in Ghent, Belgium.
REMEDENT, INC. (REMI) is rated C (2.3/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Profitability (B-); its weakest is Revisions (D+). The rating has held at C for 304 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-07-29 | C+ (2.5) | C (2.3) | B- (3.0) | C- (1.9) | D+ (1.5) | C (2.3) |
| 2020-12-31 | C+ (2.5) | C (2.2) | B- (3.1) | C- (1.9) | D (1.5) | C (2.2) |
| 2020-09-30 | C+ (2.5) | C+ (2.5) | B- (3.1) | C- (2.0) | D (1.4) | C (2.3) |